Centro de Reabilitação e Readaptação Dr. Henrique Santillo Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2009
NCT01477736
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

oxybutynin (ditropan) (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2